Physician

Daniel Robert Bensimhon, MD

According to 2025 Medicare claims, Daniel Bensimhon, MD (NPI: 1245293505) practices advanced heart failure and transplant cardiology in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is THE MOSES H CONE MEMORIAL HOSPITAL OPERATING CORPORATION (NPI: 1356372064; TIN: 581588823) and primary practice location at 27401-1020. Bensimhon is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Triad HealthCare Network, LLC. (ACO ID: D0209), participating under both the MSSP and REACH models.

Bensimhon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 625 traditional Medicare patients, billed 1,393 HCPCS/CPT codes, and received $80,555 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 8,877 prescription claims across 752 beneficiaries totaling $10,592,214 in drug costs, led by Vyndamax (Tafamidis). 2023 DME data shows 11 claims. Open Payments data shows 173 records totaling $268,613. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $196,764 to $80,555. In contrast, Part D prescription costs have moved sharply higher in recent years, from $599,895 to $10,592,214. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $122,466 to $1,336.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$98K$197K2015 Medicare payment: $196,764 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $193,110 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $153,576 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $171,641 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $159,345 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $157,336 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $143,479 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $124,942 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $106,748 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $80,555 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157393,089$196,764
20166222,924$193,110
20177092,581$153,576
20186802,730$171,641
20196382,435$159,345
20205832,139$157,336
20214511,876$143,479
20224621,694$124,942
20234261,625$106,748
20246251,393$80,555

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.3M$11M2015 Drug cost: $599,895 (USD; Tot_Drug_Cst)2016 Drug cost: $1,562,299 (USD; Tot_Drug_Cst)2017 Drug cost: $1,846,345 (USD; Tot_Drug_Cst)2018 Drug cost: $3,125,240 (USD; Tot_Drug_Cst)2019 Drug cost: $3,885,461 (USD; Tot_Drug_Cst)2020 Drug cost: $4,176,120 (USD; Tot_Drug_Cst)2021 Drug cost: $5,735,338 (USD; Tot_Drug_Cst)2022 Drug cost: $5,407,798 (USD; Tot_Drug_Cst)2023 Drug cost: $8,012,402 (USD; Tot_Drug_Cst)2024 Drug cost: $10,592,214 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155085,736$599,895
20165897,510$1,562,299
20175557,075$1,846,345
20187628,253$3,125,240
20197848,738$3,885,461
20207338,656$4,176,120
20217078,875$5,735,338
20226588,397$5,407,798
20236968,420$8,012,402
20247528,877$10,592,214

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$479K$957K2015 Medicare payment: $957,173 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $729,787 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $49,529 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $35,756 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $24,234 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $22,164 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $9,800 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,463 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $943 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015651,129$957,173
201671895$729,787
2017N/R502$49,529
2018N/R460$35,756
201911348$24,234
2020N/R466$22,164
2021N/R199$9,800
2022N/R63$2,463
2023N/R11$943
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes47118$88
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more100131$73
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function285285$49
763763d radiographic procedure5454$7
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only150180$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyndamaxTafamidis1466,120$4,407,542
OpsumitMacitentan1103,360$1,416,496
UptraviSelexipag561,644$1,296,615
EntrestoSacubitril/Valsartan87238,321$847,468
EliquisApixaban61323,681$454,054

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.171$236,329Bayer Healthcare Pharmaceuticals Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$32,285Analog Devices Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.1$126,047HeartFlow, Inc.

FAQ

What Medicare data is available for Daniel Robert Bensimhon, MD?

Tedicare shows public-source Medicare data for Daniel Robert Bensimhon, MD (NPI 1245293505), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Robert Bensimhon, MD have ACO affiliation data?

Daniel Robert Bensimhon, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Daniel Robert Bensimhon, MD?

Daniel Robert Bensimhon, MD is linked to THE MOSES H CONE MEMORIAL HOSPITAL OPERATING CORPORATION (billing NPI 1356372064) in the available physician profile data.

Does Daniel Robert Bensimhon, MD have Open Payments data?

Daniel Robert Bensimhon, MD has 173 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.